Laser in situ keratomileusis with the VISX Star laser for myopia over -10.0 diopters.
To evaluate the efficacy, predictability, stability, and safety of laser in situ keratomileusis (LASIK) for myopia over -10.00 diopters (D). The Eye Institute of Utah, Salt Lake City, Utah, USA. The prospective study included 332 eyes of 183 patients having LASIK with the VISX Star laser to correct myopia of -10.00 to -18.00 D. The eyes were divided into 3 groups according to the preoperative refraction: Group A (n = 208), -10.00 to -11.90 D; Group B (n = 94), -12.00 to -14.00 D; Group C (n = 30), -14.10 to -18.00 D. The mean follow-up was 12.0 months +/- 5.6 (SD) (range 6 to 37 months). Overall, the mean spherical equivalent decreased 96%, from -11.69 +/- 1.46 D preoperatively to -0.37 +/- 0.80 D postoperatively. The mean astigmatism decreased 72%, from 1.66 +/- 1.22 D to 0.46 +/- 0.53 D. At the last visit, 84.0% of eyes were within +/-1.00 D of emmetropia and 96.4% were within +/-2.00 D. An overcorrection of more than +1.00 D was experienced by 1.8% of patients. The uncorrected visual acuity (UCVA) was 20/20 or better in 45.8% of eyes and 20/40 or better in 89.5%. Six eyes (1.8%) lost 2 or more lines of best corrected visual acuity; this included 1 eye in which iatrogenic keratectasia developed 18 months after LASIK retreatment. Retreatment was done in 37.0% of eyes at a mean of 6.3 +/- 5.3 months (3 to 32 months) after the initial treatment. At the last examination, 86.0% of eyes in Groups A and B and 70.0% in Group C were within +/-1.00 D of emmetropia. A significant difference was found between Groups A and C (P =.032). The UCVA was 20/20 in 52.0% of Group A eyes, 38.0% of Group B eyes, and 23.0% of Group C eyes. The difference between Groups A and C was significant (P =.001), but the difference between Groups A and B was not (P =.055). In this study, LASIK was effective in correcting myopia up to -14.00 D. The efficacy, predictability, and safety were significantly less in eyes with myopia greater than -14.00 D.